SCHEMBL17001681

SCHEMBL17001681

CN1CCC(C2CCCN2C(=O)NC2CC2)CC1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ POLB P06746 2/20 0.41
▸ P2RX4 Q99571 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ HTT P42858 1/20 0.38
▸ DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18382058 1.00 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL17001689 0.95 KDM4E (0.50) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL17001683 0.88 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL18382118 0.86 SMN1; SMN2 (0.42) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL17001674 0.84 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL17001679 0.84 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL17001678 0.84 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL17001669 0.83 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL17001713 0.81 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1
SCHEMBL17001690 0.81 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015118342-A1 BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS. HEPTARES THERAPEUTICS LIMITED (GB) 2015-08-13 — — WO disclosed
Send feedback